Evercrisp Biosciences
- Biotech or pharma, therapeutic R&D
Evercrisp Therapeutics is pioneering a computational and experimental platform for the design of receptor-targeted miniproteins that enable precise, non-viral/non-LNP delivery of gene editing and oligonucleotide-based therapeutics to hard-to-reach tissues (e.g. muscle, kidney).
We are also open to collaborations to generate novel miniprotein binders to cell surface proteins enabling delivery of partner's payload to specific tissues or cells.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}